Besivance and Keratoconus - a phase IV clinical study of FDA data
We study 1,632 people who take Besivance or have Keratoconus. No report of Keratoconus is found in people who take Besivance.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Besivance?
Besivance has active ingredients of besifloxacin hydrochloride. eHealthMe is studying from 1,000 Besivance users for its effectiveness, alternative drugs and more.
What is Keratoconus?
Keratoconus (a condition in which your eye's cornea is unable to hold its round shape) is found to be associated with 254 drugs and 174 conditions by eHealthMe.
Do you take Besivance and have Keratoconus?Check whether Keratoconus is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Keratoconus and when was it recovered:
Expand to all the drugs that have ingredients of besifloxacin hydrochloride:
Alternative drugs to, pros and cons of Besivance:
- Besivance (1,000 reports)
Keratoconus treatments and more:
- Keratoconus (632 reports)
COVID vaccines that are related to Keratoconus:
- Keratoconus in Moderna COVID Vaccine
- Keratoconus in Pfizer BioNTech Covid Vaccine
- Keratoconus in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Keratoconus:
All the conditions that are associated with Keratoconus:
How the study uses the data?
The study uses data from the FDA. It is based on besifloxacin hydrochloride (the active ingredients of Besivance) and Besivance (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Clonazepam and Hip Dysplasia - now
- Dexilant and Meperidine Hydrochloride drug interaction - 6 seconds ago
- Cabergoline and Thirst - Excessive - 6 seconds ago
- Chlorzoxazone and Exalgo drug interaction - 9 seconds ago
- Spiriva Respimat and Solu-Cortef drug interaction - 12 seconds ago
- Cefobid and Hot Flushes Aggravated - 14 seconds ago
- Pyridoxine and Peripheral Swelling - 20 seconds ago
- Pramine and Apraxia - 21 seconds ago
- Isosorbide Mononitrate and Knee Joint Replacement - 21 seconds ago
- Sunitinib Malate and Dysphoria - 23 seconds ago